Reports

Drug name	NICE TAs	Comments
Temsirolimus infusion (Torisel®)	TA207 - Temsirolimus for the treatment of relapsed or refractory mantle cell lymphoma (terminated appraisal) (Negative TA) TA178 - Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma (Negative TA)	Hospital use only
Tenecteplase injection	TA52 - Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction	Hospital use only
Terbutaline nebulised		As an alternative to salbutamol nebules if salbutamol is in short supply
Terlipressin injection		Hospital use only
Testosterone gel		Use in women with low libido approved by APC (unlicensed). Specialist to initiate and issue first supply.
Testosterone implant		Hospital only - menopausal clinic
Tetracaine (Amethocaine) (Ametop®)		Paediatrics only
Tetracaine hydrochloride Minims® amethocaine hydrochloride		For hospital use only
Tezacaftor and ivacaftor (Symkevi®)		NHSE commissioning statement
Thalidomide#18.2		GAVE in renal disease

University Hospitals Birmingham NHS Foundation Trust